Company Filing History:

8 out of 1,453

Sanofi

Years Active: 1990-1996

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5565470 - Cycloaminoalkoxyphenyl derivatives, a process for their preparation as (1996-10-15),

2. 5340820 - Cycloaminoalkoxyphenyl derivatives, a process for their preparation as (1994-08-23),

3. 5223510 - Alkylaminoalkyl derivatives of benzofuran, benzothiophene, indole and (1993-06-29),

4. 5215988 - Aminoalkoxyphenyl derivatives, process of preparation and compositions (1993-06-01),

5. 5182291 - Pyrozala-pyridyl aminoabkoxyphenol compounds (1993-01-26),

6. 5039700 - Benzofuranyl aminoalkoxyphenyl compounds (1991-08-13),

7. 5028710 - Process for the preparation of derivatives of sulfonyl indolizine and (1991-07-02),

8. 5017579 - Use of aminoalkoxyphenyl derivatives for reducing and/or controlling (1991-05-21),

9. 4957925 - Aminoalkoxyphenyl derivatives, process of preparation and compositions (1990-09-18),

Title: The Innovations of Inventor Jean Lucchetti

Introduction

Jean Lucchetti is an innovative inventor based in Chastre, Belgium. With a remarkable portfolio of 9 patents, he has made significant contributions to the field of pharmacology, particularly focusing on cardiovascular and ocular health. His dedication to developing novel therapeutic compounds showcases his commitment to improving patient outcomes through innovative solutions.

Latest Patents

Lucchetti's latest patents include a range of Cycloaminoalkoxyphenyl derivatives. These compounds are designed for the treatment of various pathological syndromes affecting the cardiovascular system and ocular diseases. The patented formulations involve specific chemical structures represented by the formula, including variations where group B can represent --S--, --SO--, or --SO₂– groups. This innovation highlights his expertise in medicinal chemistry and the development of advanced therapeutic agents.

Career Highlights

Throughout his career, Jean Lucchetti has worked with prominent companies, including Sanofi and Elf Sanofi. His experience in these leading pharmaceutical firms has played a crucial role in shaping his innovative approaches to drug development. His contributions within these organizations reflect his ability to translate scientific research into practical applications that benefit healthcare.

Collaborations

In his journey as an inventor, Lucchetti has collaborated with notable professionals, including Jean Gubin and Pierre P Chatelain. These partnerships underscore the importance of teamwork and knowledge sharing in the realm of innovation, allowing for the pooling of expertise to advance their collective research initiatives.

Conclusion

Jean Lucchetti exemplifies the spirit of innovation in the pharmaceutical industry through his significant patents and collaborations. His work, especially on Cycloaminoalkoxyphenyl derivatives, positions him as a key figure in addressing critical health challenges. The impact of his inventions continues to resonate within the medical community, advancing the frontiers of therapeutic development.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com